HOME >> MEDICINE >> NEWS
One-drug therapy works for bipolar disorder

CLEVELAND -- For the first time, researchers have demonstrated in separate short-term trials that a single drug therapy may be effective in treating both the manic and depressive phases of bipolar disorder. The condition (bipolar I and II) affects approximately 8 million Americans, who have relied on a combination of drugs to manage their symptoms, and who remain at high risk of committing suicide because of the difficulty in treating the disorder.

A study of the antipsychotic drug Seroquel is published in the July issue of the American Journal of Psychiatry. The study's principal investigator is Joseph R. Calabrese, MD, principal investigator and director of the National Institute of Mental Health (NIMH) Bipolar Research Center at University Hospitals of Cleveland and Case Western Reserve University School of Medicine.

Dr. Calabrese led the randomized trial of 542 patients with bipolar depression at 39 sites in the United States. Seroquel is currently approved for the short-term treatment of acute manic episodes in bipolar I disorder and the treatment of schizophrenia. This is the first study of Seroquel in patients with both bipolar I (defined as one fully manic episode with periods of major depression) and bipolar II (defined as periods of hypomania, or high levels of energy and impulsiveness alternating with episodes of major depression), in which researchers specifically studied the drug's impact on the depressive phase of the illness. Typically, antipsychotic medications are not used as specific treatments for bipolar depression.

"Though we will soon undertake an even larger trial, these preliminary findings should shape the standard of care for bipolar disorder going forward," says Dr. Calabrese, professor of psychiatry at Case and a nationally renowned researcher in bipolar disease. The Center, which he co-directs with pediatric psychiatrist Dr. Robert Findling, is the first NIMH-funded center exclusively dedicated to the developm
'"/>

Contact: Eric Sandstrom
eric.sandstrom@uhhs.com
216-844-3825
University Hospitals of Cleveland
1-Jul-2005


Page: 1 2

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
3. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
4. Hormone therapy offers new hope for ovarian cancer patients
5. Borderline personality disorder shows improvements with intensive psychotherapy
6. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
7. Chemotherapy may enhance the effectiveness of brain tumor vaccines
8. Brain-boosting pill alleviates post-chemotherapy fogginess
9. Adding radioimmunotherapy to chemo may help patients with lymphoma
10. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
11. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... , ... Heritage Woods of Rockford Administrator Jaclyn O’Keefe has been named Administrator ... is part of the NCAL Awards Program, which recognizes exemplary assisted living caregivers. Honorees ... year’s recipients is that they all go out of their way to ensure assisted ...
(Date:8/14/2019)... ... , ... New Hampshire-based Vera Roasting Company , makers of the only ... line of CBD-infused coffees with the release of a new higher-dosage organic Wellness ... “We are excited to expand our CBD-infused product lines to include a more potent ...
(Date:8/14/2019)... ... ... Today, consumers are taking a harder look at what goes into their bodies. ... levels. The trick is finding food and beverages that are delicious and nutritious to ... created Chase – a delicious, guilt free cocktail mixer that doesn’t compromise ...
(Date:8/12/2019)... ... August 12, 2019 , ... Injured ... to donations received through the 4th annual Lockton Warfighter Sports Charity Challenge being ... , Participating in the event again this year will be fifty ...
(Date:8/9/2019)... ... August 09, 2019 , ... ... its second opioid treatment program (OTP) in Ohio. MedMark Lebanon will provide medically-supervised ... The clinic, located at 1521 Walmart Drive, is now accepting patients. , ...
Breaking Medicine News(10 mins):
(Date:8/15/2019)... , ... August 15, 2019 , ... Men’s Health Memorial ... with health care experts and learn how to regain their strength and vitality. ... taking the first step to do something about it is not always easy,” said ...
(Date:8/15/2019)... ... 2019 , ... Inc. magazine revealed that Skysis is No. ... nation’s fastest-growing private companies. The list represents a unique look at the most ... Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, and many other well-known names ...
(Date:8/14/2019)... ANDOVER, Mass. (PRWEB) , ... August 14, 2019 ... ... Andover, Massachusetts, is continuing its research and development of its drug platform GVT ... Illness (GWI), ALS, and Parkinson’s disease among others. Overwhelming data from multiple animal ...
Breaking Medicine Technology:
Cached News: